DEXCOM INC. DL-,001/ US2521311074 /
2024-04-29 7:31:54 PM | Chg. -2.26 | Volume | Bid8:04:51 PM | Ask8:04:51 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
116.28EUR | -1.91% | 0 Turnover: 0.00 |
-Bid Size: - | -Ask Size: - | 46.67 bill.EUR | - | - |
GlobeNewswire
04-08
Precision Neuroscience Names Verily Co-Founder Brian Otis as Chief Technology Officer
GlobeNewswire
01-31
Trinity Biotech Announces Acquisition of the CGM Assets of Waveform Technologies, Inc.
GlobeNewswire
2021-12-06
Integrity Applications, Inc. Expands U.S. Operations with the hiring of James P. Thrower, PhD, as Vi...